The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index; none of the 82 sources its claims cite is checked for support yet.
Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease
Open accessOverview
CoChat Summary
TL;DR
In human hippocampal tissue, GFAP isoform transcripts are differentially abundant and most increase with Alzheimer’s disease progression, while GFAPd and GFAP+1 define distinct astrocyte populations. GFAP+1 cells are a non-reactive astrocyte subset whose numbers rise with amyloid/Braak stage and can be induced by Aβ1-42 in vitro.
Key findings
- Ten GFAP transcripts were detected. With GFAPa set at 100% in amyloid O donors, median relative levels were GFAPd 1.5%, GFAPk 1.1%, GFAPz 0.21%, GFAPD135 0.24%, GFAPb 0.00120%, GFAPDEx6 0.009%, GFAPDEx7 0.006%, and GFAPD164 0.00017%; GFAPDEx6 was detected in 56/75 samples and GFAPD164 in 49/75.
- Most GFAP isoform transcripts increased with AD progression: GFAPa rose 1.3-fold in amyloid A, 2.1-fold in amyloid B, and 2.5-fold in amyloid C versus amyloid O, and increased about 2-fold at Braak 1–3 and about 3-fold at Braak 4–6. GFAPb decreased at Braak stages 3 and 4, with an 8-fold reduction at Braak 3 versus Braak 0 (0.00015% vs. 0.00120%).
- GFAPd immunostaining was prominent in subgranular zone, hilus, CA4, and stratum lacunosum-moleculare, co-localized with GFAPc-term/GFAPa, and was increased in reactive astrocytes near plaques in CA1–3 and subiculum. GFAPk protein could not be detected.
- GFAP+1 cells/cm² ranged from 4 to 82 and correlated with amyloid stage (Rs = 0.58, p < 0.001) and Braak stage (Rs = 0.59, p < 0.001), as well as plaque number density (Rs = 0.62, p < 0.001) and plaque coverage (Rs = 0.47, p < 0.001). In amyloid O–A donors, age added 0.23 GFAP+1 cells/cm² per year (Rs = 0.53, p = 0.017), and females had more GFAP+1 cells/cm² than males (32.4 ± 0.2 vs. 22.0 ± 0.2, p = 0.007). Aβ1-42 oligomers/fibrils induced GFAP+1-positive cells in U343 astrocytoma cultures.
Methods
- Post-mortem human hippocampal tissue was obtained from the Netherlands Brain Bank: 75 donors ranked by amyloid score (O, A, B, C) and Braak staged for tau, plus 10 donors without an NBB amyloid score but with tau scoring. RNA with RIN < 5.0 was excluded; qPCR for GFAP isoforms used a normalization factor based on 10 reference genes.
- Immunofluorescence was performed on lightly fixed cryosections with isoform-specific antibodies; Western blotting used recombinant GFAP isoforms expressed in SW-13cl.2 cells. Cell culture experiments used U343 astrocytoma and SW-13cl.2 cells, including Aβ1-42 oligomer/fibril treatment and MTT assays.
- GFAP+1 cells and amyloid plaques were quantified in hippocampal sections, and analyses used non-parametric methods (Kruskal-Wallis, Spearman rank correlation, Mann-Whitney U), with p < 0.05 considered significant.
Limitations
- Stated in the paper: the qPCR isoform profile is based on plasmid calibration curves and does not correct for potential different cDNA synthesis efficiencies among transcripts; GFAP+1-encoding transcripts are very low, variable, and not detectable in all samples, and it is unknown whether they originate only from GFAP+1 cells or from all astrocytes at very low abundance.
- Stated in the paper: overexpression constructs express the N-terminus of GFAPa, but the exact in vivo N-terminal head domain of GFAPD164 and GFAPDEx6 has not been determined, so the constructs may not represent endogenous GFAP+1 isoforms and filament-formation results may differ. The paper also notes it could not determine which transcript underlies GFAP+1 protein in vivo, and laser dissection of GFAP+1 cells did not yield a consistent transcript profile.
- Evident from the text: this is a human post-mortem correlational study; amyloid O donors were significantly younger than amyloid B and C donors, and age and sex effects on GFAP+1 cell numbers were observed, so AD-related increases may be partly confounded by age/sex. The paper states that whether the increase in GFAP+1 cells has consequences for the disease process cannot be derived from the data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 45 Not checked · 210 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transcript levels of most isoforms increased with AD progression.”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Many GFAPd cells were found in the stratum lacunosum-moleculare of CA1-3 and the alveus.”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“GFAPd-positive cells also stained for GFAPa.”
- Also stated in: § 3.5. GFAP isoform immunostaining · plain
“Double staining showed co-localization of GFAPd-positive astrocytes with GFAPc-term (Fig. 3E and F).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.5. GFAP isoform immunostaining · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, reactive astrocytes were found that surrounded small areas of Ab staining with a non-filamentous pattern (Fig. 3C).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transcript levels of genes encoding for other intermediate filament genes vimentin, nestin, synemin-a, and synemin-b were also increased along the same pattern as that of GFAP (Table 1).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.3. GFAP isoform transcript levels are increased in human AD
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
125 more claims
Create a free account to see all 255 claims and to verify the 75 references still open.
- It may state two separate claims as one. 99
- The quote only partly states this claim. 4
- Probably not a substantial claim. 44
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.3. GFAP isoform transcript levels are increased in human AD
“Compared to amyloid O, GFAPa levels significantly increased 1.3-fold in amyloid A, 2.1-fold in amyloid B, and 2.5-fold in amyloid C samples (Fig. 1B).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
“GFAPa 1.00 (0.82e1.67) 1.48 (1.12e1.74)1.88* (1.40e2.74)2.58*** (1.70e3.85)”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 4.2. GFAP isoform transcript levels increase in human AD
“In human cDNA samples from AD donors all GFAP isoforms were significantly increased, reaching a 1.5-to 3.2-fold increase at endstage AD (amyloid C/Braak 6).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
“GFAPD164 b 1.00 (0.06e1.50) 0.74 (0.43e1.74) 1.68 (0.59e2.90) 0.94 (0.06e3.57)GFAPDEx6 b 1.00 (0.03e1.78) 1.17 (0.91e1.36) 1.54 (0.91e3.93) 1.29 (0.23e2.38)GFAPDEx7 1.00 (0.50e1.78) 1.39 (0.99e1.87) 0.99 (0.52e1.84) 2.26 (1.15e3.28)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > Disclosure statement
“7 different isoforms are expressed in all samples”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.2. GFAP isoform transcript level profile in human hippocampus
“GFAPa, GFAPb, GFAPg, GFAPd, GFAPk, GFAPz, GFAPDEx7, and GFAPD135 transcript levels were determined in all 75 samples.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.3. GFAP isoform transcript levels are increased in human AD
“GFAPb significantly decreased in Braak stages 3 and 4, and recovered thereafter (Table 2).”
§ Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease > 3.5. GFAP isoform immunostaining
“GFAPb 1.00 (0.78e1.65) 0.83 (0.73e2.28) 0.39* (0.25e0.85) 0.33*** (0.26e0.69) 1.41 (0.88e1.80)”
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Astrocyte activation and reactive gliosis
Pekny, M., & Nilsson, M. (2005) · Glia · doi:10.1002/glia.20207 · Cited by 1,611
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Uniquely Hominid Features of Adult Human Astrocytes
Oberheim, N. A., Takano, T., Han, X., He, W., Lin, J. H. C., Wang, F., Xu, Q., Wyatt, J. D., Pilcher, W., Ojemann, J. G., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4707-08.2009 · Cited by 1,488
RNA integrity and the effect on the real-time qRT-PCR performance
Fleige, S., & Pfaffl, M. W. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.12.003 · Cited by 1,487
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
Self-citationAdult mouse astrocytes degrade amyloid-β in vitro and in situ
Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., Silverstein, S. C., & Husemann, J. (2003) · Nature Medicine · doi:10.1038/nm838 · Cited by 909
Epigenetics in Alternative Pre-mRNA Splicing
Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R., & Misteli, T. (2011) · Cell · doi:10.1016/j.cell.2010.11.056 · Cited by 796
Cited by
Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker
Yang, Z., & Wang, K. K. W. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.003 · Cited by 1,050
Hol, E. M., & Pekny, M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.004 · Cited by 917
Self-citationAstrocytes: a central element in neurological diseases
Pekny, M., Pekna, M., Messing, A., Steinhäuser, C., Lee, J.-M., Parpura, V., Hol, E. M., Sofroniew, M. V., & Verkhratsky, A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1513-1 · Cited by 755
Self-citationAutophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
Astrocyte Heterogeneity: Impact to Brain Aging and Disease
Matias, I., Morgado, J., & Gomes, F. C. A. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00059 · Cited by 387
Metadata
- Authors
- Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E.-J., Moeton, M., Freriks, M., Mizee, M. R., & Hol, E. M.
- Affiliations
- Netherlands Institute for Neuroscience (NL)
- Corresponding author
- Kamphuis, Willem
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 35
- Issue
- 3
- Pages
- 492-510
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2039930606
- Cited by
- 269
- References
- 75
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 25 · 2023: 24 · 2022: 35 · 2021: 28 · 2020: 27 · 2019: 13 · 2018: 17 · 2017: 23 · 2016: 10 · 2015: 20 · 2014: 9
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 281 d)
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Internationale Stichting Alzheimer Onderzoek (ISAO 08504)
- NANONET COST (BM1002)
- Netherlands Organization (865.09.003)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- Alzheimer's disease, glial fibrillary acidic protein, astrocyte activation, amyloid plaques, reactive astrocytes, intermediate filaments, hippocampus, disease progression, mRNA levels
- MeSH terms
- Alzheimer Disease, Astrocytes, Cells, Cultured, Glial Fibrillary Acidic Protein, Hippocampus, Humans, Severity of Illness Index, Transcription, Genetic, Up-Regulation, Gene Expression, Disease Progression, Protein Isoforms, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2013.09.035
- The paper
- Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J. A., Kooi, E.-J., Moeton, M., Freriks, M., Mizee, M. R., & Hol, E. M. (2014). Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2013.09.035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.